It’s never a good sign when a company adopts a “poison pill” plan to fend off a corporate raider.
Netflix’ recent move to thwart Carl Icahn only exposes it’s desparation after a series of missteps that sent it’s stock tumbling.
Click here to read my column in The Sunday Wall Street Journal.
